Symphony Clinical Researchå¨
Accellacare In-Home Services, operated under ICON plc, delivers decentralized clinical trial services through a global network of mobile healthcare professionals and licensed home care agencies across 60+ countries, serving top-ten pharma and biotech sponsors.
- Company typePrivate
- Founded2003
- HeadquartersVernon Hills, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Symphony Clinical Researchå¨ does
Accellacare's commercial offering targets top-ten pharmaceutical companies and small biotech organizations across Phase I-IV studies and all major therapeutic areas, with particular emphasis on rare disease and pediatric trials where reducing patient travel burden materially improves recruitment and retention. The core technology is a decentralized clinical trial infrastructure: pre-screened, licensed mobile nurses and healthcare professionals who receive protocol-specific training (including GCP), supported by home care agencies that ensure native-language coverage and local regulatory compliance. The company states 20+ years of operational experience, 500+ clinical trials brought to patients at home, and 100k+ home visits completed. Quality is governed by complete SOPs maintaining ICH/GCP, dangerous goods, and privacy rule compliance, and the platform has been successfully audited by biopharma companies, CROs, and third-party auditors. Pricing is contract-based professional services and is not publicly disclosed.
Symphony Clinical Researchå¨ firmographics
Firmographics- Name
- Symphony Clinical Researchå¨
- Website
- https://symphonyclinicalresearch.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Accellacare In-Home Services, operated under ICON plc, delivers decentralized clinical trial services through a global network of mobile healthcare professionals and licensed home care agencies across 60+ countries, serving top-ten pharma and biotech sponsors.
- Ownership category
- akta.pro rank
Symphony Clinical Researchå¨ industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
- akta.pro secondary industries
- Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where Symphony Clinical Researchå¨ is headquartered
LocationHeadquarters
- HQ city
- Vernon Hills
- HQ country
- United States
- HQ region
- North America
Markets served
Symphony Clinical Researchå¨ business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Professional services revenue generated through providing in-home clinical trial services to pharmaceutical companies and biotech organizations. Services include home visits, nursing care, and decentralized trial support delivered by mobile healthcare professionals.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Symphony Clinical Researchå¨ product offering
Product offeringCore offering
Symphony Clinical Research (operating as the Accellacare brand) provides decentralized clinical trial services to pharmaceutical and biotech sponsors. The core offering is in-home clinical trial services delivered by mobile healthcare professionals, complemented by a global site network, site resourcing, and patient voice services spanning 60+ countries. Services support Phase I-IV trials across all therapeutic areas, with particular specialization in rare disease and paediatric studies.
Product overview
Accellacare is a clinical research network operated by ICON plc, offering a unified platform of decentralized clinical trial services. The core offering consists of In-Home Services, which brings clinical trial visits directly to patients through mobile healthcare professionals, complemented by the Site Network (including Global Neuroscience Research Capabilities), Site Resourcing, and Patient Voice services. Together, these services enable pharmaceutical and biotech sponsors to conduct decentralized trials with global reach across 60+ countries, improving patient recruitment and retention.
Differentiator
Problem solved
Functional benefit
Products and services
- Accellacare In-Home Services A comprehensive suite of home trial services that brings clinical trial visits directly to patients, conducted by highly skilled mobile healthcare professionals. Provided on a stand-alone basis or as part of an integrated ICON decentralized trial solution. Targets pharmaceutical and biotech sponsors running Phase I-IV trials across all therapeutic areas.
- Accellacare Site Network A global network of clinical research sites supporting patient recruitment and clinical trial delivery across multiple therapeutic areas. Targets pharmaceutical and biotech sponsors needing site infrastructure for clinical trials.
- Accellacare Site Resourcing Staffing and resourcing solutions for clinical trial site operations. Provides workforce support for sponsors and CROs managing trial sites.
- Patient Voice Services Patient-centric services focused on incorporating patient perspectives and feedback into clinical research. Supports sponsors in integrating the patient voice into study design and execution.
- Global Neuroscience Research Capabilities Specialized clinical research capabilities in neuroscience, offered as a specialization within the Site Network. Targets sponsors conducting neurology clinical trials requiring deep therapeutic expertise.
Quantifiable outcome
- 500+ clinical trials brought to patients at home
- +2 more outcomes
Companies that use Symphony Clinical Researchå¨
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Symphony Clinical Researchå¨ technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Symphony Clinical Researchå¨ partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Symphony Clinical Researchå¨ competitors and assessment
Company assessmentDirect peers
- Clario: Clario provides decentralized clinical trial technology and in-home clinical services to biopharma sponsors, overlapping directly with Symphony/Accellacare's DCT service portfolio.
- Science 37: Science 37 is a decentralized clinical trial company that brings trials directly to patients via a mobile research nurse model, directly overlapping with Symphony/Accellacare's in-home service offering.
- Medable: Medable is a leading decentralized trial technology platform that integrates eCOA, ePRO, telehealth, and in-home services for sponsors, increasingly competing with service-led in-home providers like Symphony/Accellacare.
- Signify Health (VirTrial): Signify Health, through its VirTrial acquisition, offers in-home and remote clinical trial services leveraging a nationwide mobile clinician network, directly comparable to Symphony/Accellacare's home-visit model.
Broad incumbents
- ICON plc: ICON plc is the global CRO within which Accellacare In-Home Services is operated, and is therefore the most directly comparable entity in terms of sponsor relationships, clinical operations infrastructure, and DCT strategy.
- Thermo Fisher Scientific (PPD): Thermo Fisher's PPD clinical research business is one of the largest global CROs with broad decentralized trial capabilities, competing for the same enterprise pharma and biotech in-home and site services work as Symphony/Accellacare.
- IQVIA: IQVIA is the largest global CRO with significant decentralized trial and in-home clinical services capabilities, competing head-to-head with Symphony/Accellacare for enterprise pharma and biotech sponsors.
- Medpace Holdings: Medpace is a mid-to-large global CRO serving pharma and biotech sponsors across all phases of clinical development, directly competing for the same Phase I–IV trial work that Symphony/Accellacare supports.
- Syneos Health: Syneos Health is a large biopharma solutions organization offering CRO and decentralized clinical trial services, competing with Symphony/Accellacare for enterprise in-home and site support engagements.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a global CRO with site management and decentralized capabilities serving pharma and biotech sponsors, comparable in clinical trial service scope to Symphony/Accellacare.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Symphony Clinical Researchå¨ social profiles
Digital presenceSymphony Clinical Researchå¨ compliance and trust
Trust signalCompliance2 records
Symphony Clinical Researchå¨ financial estimates
Financial estimateRevenue estimate
Valuation estimate
Symphony Clinical Researchå¨ leadership team
Management profileNumber of profiles
Symphony Clinical Researchå¨ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Symphony Clinical Researchå¨ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Symphony Clinical Researchå¨
What does Symphony Clinical Researchå¨ do?
Symphony Clinical Research (operating as the Accellacare brand) provides decentralized clinical trial services to pharmaceutical and biotech sponsors. The core offering is in-home clinical trial services delivered by mobile healthcare professionals, complemented by a global site network, site resourcing, and patient voice services spanning 60+ countries. Services support Phase I-IV trials across all therapeutic areas, with particular specialization in rare disease and paediatric studies.
When was Symphony Clinical Researchå¨ founded?
Symphony Clinical Researchå¨ was founded in 2003. It employs 11 to 50 people.
Where is Symphony Clinical Researchå¨ based?
Symphony Clinical Researchå¨ is headquartered in Vernon Hills, United States, in the North America region.
How does Symphony Clinical Researchå¨ make money?
One revenue line is on record: clinical Research Services.
Who are Symphony Clinical Researchå¨'s main competitors?
Direct peers on record are Clario, Science 37, Medable and Signify Health (VirTrial). Broad incumbents are ICON plc, Thermo Fisher Scientific (PPD), IQVIA, Medpace Holdings, Syneos Health and Worldwide Clinical Trials.
Does Symphony Clinical Researchå¨ have an API?
No public API is recorded for Symphony Clinical Researchå¨.
What industry is Symphony Clinical Researchå¨ in?
Symphony Clinical Researchå¨'s product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 6215 and its SIC code is 8000.